These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 334673)

  • 1. [Azlocillin and mezlocillin: two new semisynthetic acylureido-penicillins (author's transl)].
    Lode H; Niestrath U; Koeppe P; Langmaack H
    Infection; 1977; 5(3):163-9. PubMed ID: 334673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin.
    Pickering LK; Rutherford I
    J Pharmacol Exp Ther; 1981 May; 217(2):345-9. PubMed ID: 6453219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiences using acylureido-penicillins (azlocillin, mezlocillin) in pediatrics].
    Weingärtner L; Sitka U; Patsch R; Thiemann HH
    Klin Padiatr; 1984; 196(1):28-35. PubMed ID: 6694339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of infusion rate on pharmacokinetic parameters of azlocillin and mezlocillin].
    Haen E; Remien J; Richter E; Frank U; Adam D
    Arzneimittelforschung; 1985; 35(5):864-8. PubMed ID: 4026911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic studies of azlocillin, mezlocillin, cephalothin and sisomicin in rabbits.
    Dzierzanowska D; Patzer J; Jeljaszewicz J
    Infection; 1982; 10 Suppl 3():S217-20. PubMed ID: 6218118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pediatric pharmacology of azlocilin (author's transl)].
    Sitka U; Weingärtner L; Patsch R; Richter I
    Padiatr Padol; 1979; 14(4):429-40. PubMed ID: 530731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo action of mezlocillin and azlocillin combined with sisomicin.
    Dzierzanowska D; Jeljaszewicz J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):346-55. PubMed ID: 6417945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro activity of mezlocillin, azlocillin and carbenicillin against bacteroidaceae with particular reference to bacteroides fragilis (author's transl)].
    Werner H; Krassemann C; Ungerechts J; Schmitz HJ
    Infection; 1977; 5(1):17-21. PubMed ID: 585371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of mezlocillin and carbenicillin.
    Pancoast SJ; Neu HC
    Clin Pharmacol Ther; 1978 Jul; 24(1):108-16. PubMed ID: 657712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azlocillin and mezlocillin: new ureido penicillins.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1978 Jun; 13(6):930-8. PubMed ID: 677860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of therapeutic efficacy of ureidopenicillins in comparison to sisomicin and cephalotin in experimental infections of rabbits.
    Dzierzanowska D; Klosinska E; Roszkowski W; Patzer J; Jeljaszewicz J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Sep; 250(3):312-21. PubMed ID: 6458186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Degradation of Azlocillin and Mezlocillin / I. Behaviour in biological material and buffer (author's transl)].
    Gundert-Remy U; Weber E
    Arzneimittelforschung; 1981; 31(12):2041-4. PubMed ID: 6460506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiology, pharmacology, and clinical use of mezlocillin sodium.
    McCloskey RV; LeFrock JL; Smith BR; Aronoff GR
    Pharmacotherapy; 1982; 2(6):300-12. PubMed ID: 6220263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmakokinetic and clinical studies with azlocillin in paediatrics (author's transl)].
    Weingärtner L; Sitka U; Patsch R; Richter I; Thiemann HH
    Klin Padiatr; 1980 Sep; 192(5):419-29. PubMed ID: 7192337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro susceptibility of gram-negative bacteria isolated from urinary tract infections to acylureidopenicillins].
    Cerikcioğlu N; Ustaçelebi S; Günalp A
    Mikrobiyol Bul; 1986 Jul; 20(3):139-44. PubMed ID: 3561279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins.
    Eliopoulos GM; Moellering RC
    Ann Intern Med; 1982 Nov; 97(5):755-60. PubMed ID: 6215872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibacterial activity of mezlocillin and azlocillin/A survey (author's transl)].
    Knothe H
    Arzneimittelforschung; 1979; 29(12a):1916-20. PubMed ID: 120745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
    Høiby N; Bremmelgaard A; Schouenborg P
    Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro effect of acylureido penicillins and mezlocillin on anaerobic sporeless gram-negative rods of genus Bacteroides].
    Höhne C
    Infection; 1982; 10 Suppl 3():S238-43. PubMed ID: 6218120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of the binding of acylureidopenicillins and carbenicillin to human serum proteins.
    Rosenkranz H; Förster D
    Infection; 1979; 7(3):102-8. PubMed ID: 478650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.